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Risk Ratio Estimation in Case-Cohort Studies
Tosiya Sato
Institute of Statistical Mathematics, Tokyo, Japan
In traditional (cumulative-incidence) case-control studies, the exposure odds ratio can be used as an estimator of the risk ratio only when the disease
under study is rare. The case-cohort study is a recently developed useful modification of the case-control study. This design allows direct estimation
of the risk ratio from a fixed cohort, but does not require any rare-disease assumption. This article reviews recent developments in risk ratio estima-
tion procedures for the analysis of case-cohort data. In the crude analysis, it is shown that the empirical risk ratio estimator is not fully efficient, and
the maximum likelihood estimation of the crude risk ratio is discussed. In the stratified analysis, several common risk ratio estimation procedures
and standardization methods have been proposed for large strata. However, the Mantel-Haenszel risk ratio and its variance estimator are the only
available methods for sparse data. - Environ Health Perspect 102(Suppl 8):53-56 (1994)
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Introduction
Cohort and case-control studies are well
established epidemiologic designs for
studying individual level exposure-disease
relationship. Suppose we are interested in
estimating a risk ratio that is a ratio ofinci-
dence proportions between the exposed
and unexposed populations. In fixed cohort
studies, the exposed and unexposed sub-
jects, initially disease-free, are followed over
a given risk period. We then ascertain dis-
ease-specific incidence proportions between
these two groups and have an estimate of
the risk ratio. In traditional case-control
studies, cases of a study disease are sampled
from all incident cases in a fixed cohort and
controls are sampled from noncases, the
population at risk at the end of the risk
period. Exposure histories among cases and
controls are identified retrospectively and
compared. In such a cumulative-incidence
sampling ofcontrols (1), we cannot estimate
incidence proportions without external
information. However, we may use the
exposure odds ratio as a good approxima-
tion of the risk ratio when the disease
under study is "rare" (2).
In 1975, Kupper et al. (3) proposed a
useful modification of traditional case-con-
trol studies. In their design, cases are sam-
pled from all incidence cases, which is the
same as traditional case-control studies; but
controls are sampled from the initial cohort
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members (the population at risk at the start
ofthe risk period) regardless oftheir future
disease status. This design allows estima-
tion of the risk ratio without the need for
the rare-disease assumption. Since it is a
compromise between fixed cohort and
case-control studies, Kupper et al. called it
the hybrid epidemiologic design. It is also
called the case-base (4) or case-cohort (5)
study, because the control group is a sample
from the study "base" or the full cohort.
(Some use the term case-base for risk ratio
estimation and case-cohort for incidence
rate ratio estimation (6), but I use the
term case-cohort throughout the article.)
In this article, I will review recent
developments in risk ratio estimation pro-
cedures in case-cohort studies, and discuss
the maximum likelihood method and
sparse risk ratio estimation.
Crude Analysis
Suppose that a fixed cohort of Ninitially
disease-free subjects are followed for a
given risk period and that Mout ofNsub-
jects develop a disease under study by the
end ofthe risk period. In case-cohort stud-
ies, m cases are randomly selected from the
total of Mincident cases with a sampling
proportion rl; and n controls (subcohort)
are randomly selected from the Ninitial
cohort members with a sampling propor-
tion ro (3,4). We assume that (N,M) and
(rl, ro) are unobservable.
The subcohort may contain cases (7);
some are included in the case sample and
some are not. The observed and expected
counts in the case-cohort sample are shown
in Table 1. Herep1 andpo are incidence
proportions in the exposed and the unex-
posed, and p, is the exposure prevalence in
the initial cohort. Let a-=ao+al+a2 and
b+=bo+bl+b2, which are all the exposed and
the unexposed cases, e=al+a2andf=bl+b2,
the exposed and the unexposed cases in
the subcohort, and nl=al+a2+c and
n6=bl+b2+d, the exposed and the unex-
posed in the subcohort.
We assume that the appropriate effect
measure is the risk ratio which is defined by
P- P(EID)/[1-P(EI D)
Tpo Pe (1 Pe)
where P(EID) is the exposure prevalence in
diseased cases. Since a l/b and n1/no consis-
tently estimate P(EID)I[1-P(EID)] and
Pe'(I-pe), respectively, the empirical esti-
mator ofthe crude risk ratio (3,4) is given by
noa+ [1]
Kupper et al. (3) considered the situation
that the sampled cohort was the target pop-
ulation. As criticized by Mantel (8), they
failed to take account ofrandom incidence
variation, and hence their confidence inter-
val method is not valid for inference
beyond that cohort. The correct variance
estimate oflog'Eis given by
=1 1(e+fY1' V - +-+ i-2ii+- VE a +b+ a++b+)(n, no)
which is independently derived by
Greenland and Nurminen (S. Greenland,
personal communication, 1992), reported
in Miettinen (4). When the full cohort is
observed (r =r=1), E turns to the full
cohort risk ratio, and VEbecomes identical
to the variance estimator of its logarithm.
When the subcohort has no cases, OE turns
to the odds ratio and VEbecomes identical
to thevariance estimatoroflogodds ratio (9).
For risk ratio estimation in Equation 1,
we do not exclude the cases from the sub-
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cohort. Miettinen (4), however, noted that
we should make a usual case and noncase
comparison, as in traditional case-control
studies, when testing zero exposure effect.
He gave the simple Pearson chi-square sta-
tistic given by
X2- t(a+d -bc)
(a++b+)(a++c)(b++d)(c+d)
where t=a++b++c+d, the total number of
distinct subjects in the case-cohort sample.
Given that the exposure has no effect, X0
has an approximately chi-square distribu-
tion with one degree offreedom (d.f.).
Example 1. Miettinen (4) considered a
case-cohort data which are ao = 5, e = 5,
c=5, bo=35f= 15, and d=75. The test of
zero exposure effect gives Xo=3.89 with
P value=0.049. The empirical risk ratio
estimate and the variance estimate of its
logarithm are E = 1.80 and VE=O.157,
yielding the logarithm based 95% limits
for the crude risk ratio of 1.80 exp(± 1.96
40.157)=(0.83, 3.91).
Since the test and the confidence inter-
val method in the above example are
inconsistent, Nurminen (9) proposed the
alternative test for zero exposure effect.
Noting that OE is the solution to the fol-
lowing estimating equation
noa+--n1b+=O,
he used the null asymptotic distribution of
the contrast noa+-nlb+ for testing =1.
The test statistic is given by
X2 =(noa+ -nlb+)2 [31
lnon(a++b+)
which has an approximately chi-square dis-
tribution with one d.f.
Nurminen's test gives that X2=2.96
and Pvalue=0.085. The result is consis-
tent with the previous 95% limits of0.83
and 3.91.
The empirical contrast used in the test
statistic (Equation 3) is decomposed by
noa+-nIb+=(a+d-b+c)+(aJ--boe),
where the first term in the right hand side
is the case and noncase contrast used in
Equation 2. From the expected counts
given in Table 1, it is clear that E(aOf) =
E(boe). This means the expectation of the
second term is zero regardless ofthe value
of 0. Consequently, Nurminen's test is
conservative because it takes random varia-
Table 1. Observed and expected counts in the case-cxohort sample.
Exposed
Cases
Case sample only
Case and subcohort
Subcorhort only
Noncases
ao Nr(l-ro)plPe
al NrlroPiPe
a2 N(l-ri)roPlPe
c Nro(l-P1)Pe
tion ofajf-boe. Since the empirical risk
ratio estimator E has the same problem,
we may have a more efficient estimator
when we substitute a common estimate
between E(a0f) and E(boe) into OE. The
simplest choice is (aOf+bOe)12 as an esti-
mate ofE(aof)= E(boe). The resulting risk
ratio estimator is given by
A' a+d+[a+f+b+e]/2
b+c +[a+f+b+e]/2
and the large-sample variance of its loga-
rithm is
A (lo
A A Var (log4E)=var (logObE)+
ri
-ro)(pi +Po)
4roR
Fpo -3p, + p, -3Po l
PiPe Po(1 Pe)j
where varA is the asymptotic variance and
R=rl-rlro+rQ. When 1/3<.<3, it holds
that varA(logOE)<varA(logE); however the
large-sample variance oflogE is not always
smaller than that oflogOE.
What does E(a0f)=E(boe) mean?
Consider a 2x2 table of all cases in the
case-cohort data in which entries are the
exposed and the unexposed cases only in
the case sample (ao,bo) and in the subco-
hort (e,f). The equation E(a0f)=E(boe)
means this 2x2 table ofall cases is struc-
turally independent. Then the null expec-
tations for the cases in the subcohort
become
e=a+ e+f andf=b e+f
a+a+b+ a + b+
Using these expectations we have a new
risk ratio estimator
[4]
A
noa+
M lb+
Unexposed
bo Nrl(1-ro)po(l-pe)
b1 Nrlropo(1-pe)
b2 N(l-rl)ropol(-Pe)
d Nro(l-po)(l-Pe)
where fl1=e+c and fio=f+d. Under the
multinomial model with the expectations
given in Table 1, this estimator is the max-
imum likelihood estimator (10). The
large-sample variance estimator oflogOML is
given by
VML = ++ l-2ef a+ b+ a+ +b+)
(1+ 1 n2a+b+(ao +bo)(e +f)
tni no) (a +b I )no
Since the last term in the right hand side is
negative, VML is always smaller than VE.
Surprisingly, the efficient score test for
0=1 is identical to the chi-square test,
Equation 2, proposed by Miettinen (4).
The maximum likelihood approach
gives that OML= 2.20 andVML=°0132,
yielding the 95% limits of 2.20
exp(±1.960I132)=(1.08, 4.48). This
confidence interval is consistent with
Pvalue=0.049 from Equation 2.
Stratified Analysis
Since any real study will require adjust-
ment for confounding factors, we next
consider the stratified analysis. Suppose the
subjects are stratified into Kstrata by sev-
eral confounders. With obvious notation,
Kupper et al. (3) proposed the summary
risk ratio which was given by
A= no Xknka+kl(a+k+b+k)
ni Eknkb+k /(a+k+ b+k)
where summations are over all strata.
Greenland (11) showed that this summary
risk ratio is asymptotically biased. The
large-strata expectation becomes
X, NkPekPlk
EA('K) 1-P' PekPIk +(1 Pek)POk
OK) PI Nk(l-Pek)POk
PekPIk + (1- Pek)POk
with simple random sampling of the cases
and the subcohort. Kupper et al.'s sum-
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mary risk ratio is neither consistent for the
standardized morbidity ratio (SMR)
OSMR = ikNkPekPIk
XkNkPekPOk
nor any other epidemiologically meaning-
ful standardized risk ratio. Even when the
risk ratios are constant across strata that
q)k=q) the large-strata expectation ofOPK
becomes
NkPek
EAOK¢) _1PI NPek (1 Pk)
Y,k Pek + ( -Pek)
It does not reduce to the common value '
except when 0=1.
The unbiased adjustment methods have
been given by Greenland (11). Applying
Miettinen's arguments (12), he derived the
SMR estimator by
OSMR =
nknb1k+k 'nOk
and the large-strata variance estimator ofits
logarithm
V 2 V/2 VS~MR=XYka+kYVEkI/a+.
We may use the stratum-specific maximum
likelihood estimators in the SMR estimator
(10).
Modifications are quite simple: change
the number of the exposed and the unex-
posed in the subcohort (nik,nok) to their
maximum likelihood estimators (ilk,fiod
We then have the efficient SMR estimator
and the variance ofits logarithm
a+ and
'PSMR XkflIkb+k 8Oka
VSMR =ka+kVMLk Ia+k
Other standardization methods (13) that
have reasonable interpretation are available
(10).
Although the SMR does not require
risk ratio homogeneity, we will have a more
efficient estimator for the common risk
ratio when the stratum-specific risk ratios
are common across strata. By analogy with
the Mantel-Haenszel odds ratio (14),
Miettinen (15) gave a Mantel-Haenszel
like risk ratio, which is expressed by
= _ 7knOka+kl(a+k+b+k+nk)
'm Xknlkb+kl(a+k+b+k+nk)
Since Miettinen failed to account for the
overlap between a+kt+b+k and nk, i.e.,
ek+fk, OPM have to be modified (9).
Greenland (11) gave two closed-form
Mantel-Haenszel type estimators for the
common risk ratio. One is the Tarone esti-
mator:
A XknOka+k'Sk OT = Xknlkb+k/Sk
where sk=aOk+bOk+ck+dk. It is the inverse
null variance weighting of the stratum-
specific risk ratios, and asymptotically fully
efficient under zero exposure effect. When
we study the full cohort, OT becomes iden-
tical to the Tarone estimator for the com-
mon risk ratio (16). The other is the
Mantel-Haenszel estimator:
A XknOka+k Itk
'MH Eknlkb+k Itk
where tk=a+k+b+k+ck+dk, the total number
ofdistinct subjects in the kth stratum. The
Mantel-Haenszel estimator is dually consis-
tent for ', that is, consistent in both the
large-strata and the sparse-data (the num-
ber of strata Kbecomes large, as in the
matched sample), while the Tarone estima-
tor is consistent only in the large-strata.
Greenland (11) gave the large-strata
variance estimator oflogOT (and implicitly
oflog
A ). The dually consistent variance
estimator oflog'MH is given by
VMH- =kWk/tk
(XknOka+k Itk)(Xknlkb+k Itk)
where Wk=(bok+d)flika,k+(aOk+Ck)nlkb+k+
aokdk+bokck (17). With the full cohort
observed, VMH becomes identical to the
Mantel-Haenszel variance derived by
Greenland and Robins (18). By changing
tks in V.H to Sk, we have the variance esti-
mator oflog T, but it is consistent only in
the large strata. The confidence interval
method based on the estimating function is
also proposed (17).
Three other large-strata common risk
ratio estimators, more efficient than the
Tarone or the Mantel-Haenszel estimator,
are available. Greenland (11) gave the
Woolf (the weighted least squares) estima-
tor based on the stratum-specific empirical
risk ratios. Using the corresponding maxi-
mum likelihood estimators, we have the
modified Woolfestimator
logA* - Y.klog'MLk/VMLk
Xwkl1/VMLk
and the large-strata variance estimator of
log+* ow
VW4=(Ik1 'IVMLk)
The following two estimators do not have a
closed form. Nurminen (9) proposed an
estimator as an extension ofthe cohort chi-
square function approach (19). Nurminen's
estimator is the solution to the estimating
equation
z nOka+,knlkb+k -o
PIk + nOk
He gave a score-like interval for ( based on
the asymptotic distribution of the above
estimating function. Sato (10) proposed the
maximum likelihood estimator for the
common risk ratio. It requires the iterative
solution of a set of 3K+1 score equation
for (', {rik, rok,Pek})' or K+3 for (¢X r1l r0,
{lPek}) under a certain design situation, for
example, simple random sampling of the
cases and the subcohort.
For the test of zero exposure effect,
extending the case and noncase comparison
in the crude analysis, the Mantel-Haenszel
test statistic is given by
x2
MH
[a+-Xk(a+k+Ck)(a+k+b+k )Itk]2
(a+k+b+k)(ck+dk)(a+k+ck)(b+k+dk)
tk(tk-1)
which has an asymptotically chi-square dis-
tribution with one degree of freedom
under zero exposure effect (11,15). This
test is applicable to both large-strata and
the sparse-data cases.
Example 2. Consider a stratified case-
cohort data with K=2: a01=74, a11=4,
a21=5, c1=75, b01=2, bi1=O, b2l=O, and
d1=19 for stratum 1; and a02=8, a12=0,
a22=1, c2=41, bo2=6, b-2=1, b22=0, and
d2=190 for stratum 2 (10,17). The
Mantel-Haenszel test gives XMH=26.7
with P value=0.0, highly significant.
Several summary risk ratios and 95%
confidence intervals are shown in Table 2.
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Table 2. Summary risk ratios.
4', 95% Cl
Common risk ratio
Tarone 7.45 (3.00, 18.5)
Mantel-Haenszel 7.41 (3.01, 8.13)
Woolf 6.85 (2.95, 15.9)
Nurminen 6.96 (3.23, 14.9)
Maximum likelihood 6.96 (3.08, 15.7)
Indirect standardization
SMR 8.86 (2.34, 33.5)
Modified SMR 8.96 (2.37, 33.8)
The upper half ofTable 2 gives the com-
mon risk ratio estimates and the lower half
the indirect standardization. The Tarone
and the Mantel-Haenszel risk ratios give the
virtually the same results. The Woolf,
Nurminen, and maximum likelihood also
give dose point estimates, but the Nurminen
method gives the narrower 95% interval.
The two SMR estimates are also close.
Concluding Remarks
In the crude analysis of the case-cohort
data, the maximum likelihood estimator
for the risk ratio should be used. It is more
efficient than the empirical risk ratio esti-
mator and easy to compute. The chi-square
test given by Miettinen (4) is still valid,
because it is identical to the efficient score
test. In the stratified analysis, there are several
options for summary risk ratio estimation
in large strata. Greenland (11) gives tenta-
tive recommendations on choosing
between large-strata estimators. When the
data are sparse, the Mantel-Haenszel esti-
mator is the only available common risk
ratio estimator. We may improve its
efficiency simply using the contrasts
nOka+k flkb+k rather than noka+k-On b
The modified Mantel-Haenszel estimator
becomes
AS knOka+kItk
M knlkb+kItk
and OkH=7.45 for Example2. However, it is
difficult to derive a variance estimator for it.
This article has reviewed recent devel-
opments in risk ratio estimation procedures
in case-cohort studies when censoring is
unimportant. Ifcensoring is important, the
risk ratio estimate not adjusted for it is mis-
leading (20) and the correct risk ratio esti-
mation procedure is proposed by Flanders
et al. (21). When time to response is ofpri-
mary concern, incidence rate ratio (hazard
ratio) estimation is available (5).
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